A Study of ARV-393 in Relapsed/Refractory Non-Hodgkin Lymphoma.

Clinical trial NCT06393738 · RECRUITING

Trial details

NCT number: NCT06393738
Sponsor: Arvinas Inc.
Status: RECRUITING
Phase: Phase 1
Study type: INTERVENTIONAL

Relapsed/Refractory (R/R) Mature B Cell Non Hodgkin Lymphoma (NHL)Relapsed/Refractory (R/R) Angioimmunoblastic T-cell Lymphoma (AITL)

Start date: 2024-09-05
Primary completion: 2028-03-01
Enrollment: 255

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.